BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 33020465)

  • 1. Acute Rejection and Infectious Complications in ABO- and HLA-Incompatible Kidney Transplantations.
    Ko Y; Kim JY; Kim SH; Kim DH; Lim SJ; Shin S; Kim YH; Jung JH; Park SK; Kwon H; Han DJ
    Ann Transplant; 2020 Oct; 25():e927420. PubMed ID: 33020465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome of desensitization in human leukocyte antigen and ABO incompatible living donor kidney transplantation: Single center experience of first 200 incompatible transplants.
    Pandey P; Setya D; Sinha VK; Devra AK; Bhatt AP; Pande A; Kumar P; Singh MK; Ranjan S
    J Clin Apher; 2021 Jun; 36(3):299-312. PubMed ID: 33316838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Difference in outcomes after antibody-mediated rejection between abo-incompatible and positive cross-match transplantations.
    Couzi L; Manook M; Perera R; Shaw O; Ahmed Z; Kessaris N; Dorling A; Mamode N
    Transpl Int; 2015 Oct; 28(10):1205-15. PubMed ID: 26095452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Excellent outcome after desensitization in high immunologic risk kidney transplantation.
    Lim JH; Cho JH; Jung HY; Choi JY; Park SH; Kim YL; Kim HK; Huh S; Yoo ES; Won DI; Kim CD
    PLoS One; 2019; 14(9):e0222537. PubMed ID: 31550258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical outcomes of ABO- and HLA-incompatible kidney transplantation: a nationwide cohort study.
    Ko EJ; Yu JH; Yang CW; Chung BH;
    Transpl Int; 2017 Dec; 30(12):1215-1225. PubMed ID: 28493630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term Follow-up of ABO-Incompatible Kidney Transplantation in Freiburg, Germany: A Single-Center Outcome Report.
    Langhorst C; Ganner A; Schneider J; Prager EP; Walz G; Pisarski P; Jänigen B; Zschiedrich S
    Transplant Proc; 2021 Apr; 53(3):848-855. PubMed ID: 33041078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful ABO and HLA incompatible kidney transplantation in children in the UK.
    Hew EY; Kessaris N; Stojanovic J; Jones H; Christian M; Edwards A; Milford DV; Ognjanovic M; Shenoy M; Baker RJ; Marks SD
    Pediatr Nephrol; 2023 Feb; 38(2):529-535. PubMed ID: 35695967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful launch of an ABO-incompatible kidney transplantation program to overcome the shortage of compatible living donors: experience at a single center
.
    Song SH; Lee J; Kim BS; Kim S; Lee JG; Jeong HJ; Kim YS; Kim MS; Kim HO; Kim SI; Huh KH
    Clin Nephrol; 2017 Sep; 88(9):117-123. PubMed ID: 28679466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome of ABO Blood Type-Incompatible Living-Related Donor Kidney Transplantation Under a Contemporary Immunosuppression Strategy in Japan.
    Hamano I; Hatakeyama S; Fujita T; Murakami R; Hamaya T; Togashi K; Suzuki Y; Yamamoto H; Yoneyama T; Yoneyama T; Hashimoto Y; Narumi S; Tomita H; Ohyama C
    Transplant Proc; 2020; 52(6):1700-1704. PubMed ID: 32448659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Patterns Discriminate Accommodation and Subclinical Antibody-mediated Rejection in Kidney Transplantation.
    Hruba P; Krejcik Z; Stranecky V; Maluskova J; Slatinska J; Gueler F; Gwinner W; Bräsen JH; Wohlfahrtova M; Parikova A; Osickova K; Fronek J; Seda O; Prefertusova L; Honsova E; Viklicky O
    Transplantation; 2019 May; 103(5):909-917. PubMed ID: 30801516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of ABO-Incompatible Living Donor Kidney Transplantation on Patient Survival.
    Massie AB; Orandi BJ; Waldram MM; Luo X; Nguyen AQ; Montgomery RA; Lentine KL; Segev DL
    Am J Kidney Dis; 2020 Nov; 76(5):616-623. PubMed ID: 32668318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes and risk stratification for late antibody-mediated rejection in recipients of ABO-incompatible kidney transplants: a retrospective study.
    Lonze BE; Bae S; Kraus ES; Holechek MJ; King KE; Alachkar N; Naqvi FF; Dagher NN; Sharif A; Desai NM; Segev DL; Montgomery RA
    Transpl Int; 2017 Sep; 30(9):874-883. PubMed ID: 28403566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early hospital readmissions after ABO- or HLA- incompatible living donor kidney transplantation.
    Lee J; Kim DG; Kim BS; Kim MS; Il Kim S; Kim YS; Huh KH
    Sci Rep; 2019 Mar; 9(1):3246. PubMed ID: 30824777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infection Risk in the First Year After ABO-incompatible Kidney Transplantation: A Nationwide Prospective Cohort Study.
    Hirzel C; Projer L; Atkinson A; Surial B; Mueller NJ; Manuel O; Mombelli M; van Delden C; Hirsch HH; Boggian K; Walti LN; Sidler D; Hadaya K; Dickenmann M; Müller TF; Binet I; Golshayan D; Huynh-Do U;
    Transplantation; 2022 Sep; 106(9):1875-1883. PubMed ID: 35389968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Borderline rejection in ABO-incompatible kidney transplantation.
    Sánchez-Escuredo A; Oppenheimer F; Solé M; Revuelta I; Cid J; Lozano M; Blasco M; Esforzado N; Ricart MJ; Cofán F; Torregrosa JV; Paredes D; Musquera M; Ercilla G; Campistol JM; Diekmann F
    Clin Transplant; 2016 Aug; 30(8):872-9. PubMed ID: 27146439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. One hundred ABO-incompatible kidney transplantations between 2004 and 2014: a single-centre experience.
    Zschiedrich S; Jänigen B; Dimova D; Neumann A; Seidl M; Hils S; Geyer M; Emmerich F; Kirste G; Drognitz O; Hopt UT; Walz G; Huber TB; Pisarski P; Kramer-Zucker A
    Nephrol Dial Transplant; 2016 Apr; 31(4):663-71. PubMed ID: 26610596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of simultaneous presence of anti-blood group A/B and -HLA antibodies on clinical outcomes in kidney transplantation across positive crossmatch: a nationwide cohort study.
    Kwon H; Kim JY; Kim DH; Ko Y; Choi JY; Shin S; Jung JH; Kim YH; Han DJ;
    Sci Rep; 2019 Dec; 9(1):18229. PubMed ID: 31796812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ABO-incompatible pediatric kidney transplantation without antibody removal.
    Kawamura T; Hamasaki Y; Takahashi Y; Hashimoto J; Kubota M; Muramatu M; Itabashi Y; Hyodo Y; Ohashi Y; Aikawa A; Sakai K; Shishido S
    Pediatr Nephrol; 2020 Jan; 35(1):95-102. PubMed ID: 31673829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of rituximab dose on infectious complications in ABO-incompatible kidney transplantation.
    Lee J; Lee JG; Kim S; Song SH; Kim BS; Kim HO; Kim MS; Kim SI; Kim YS; Huh KH
    Nephrol Dial Transplant; 2016 Jun; 31(6):1013-21. PubMed ID: 27190360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single cohort study: ABO-incompatible kidney transplant recipients have a higher risk of lymphocele formation.
    Jänigen BM; Salabè C; Glatz T; Thomusch O; Lässle C; Fichtner-Feigl S; Zschiedrich S; Pisarski P
    Langenbecks Arch Surg; 2019 Dec; 404(8):999-1007. PubMed ID: 31456076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.